NCT00591825View on ClinicalTrials.gov

fMRI Study Examining Effects of D-cycloserine in Specific Phobia

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Phobias
Interventions
DRUG

D-cycloserine

D-cycloserine

DRUG

Placebo

Placebo

Trial Locations (1)

66160

University of Kansas Medical Center, Hoglund Brain Imaging Center, Kansas City

All Listed Sponsors
collaborator

American Psychological Foundation

OTHER

collaborator

American Psychological Association

UNKNOWN

lead

University of Kansas Medical Center

OTHER

NCT00591825 - fMRI Study Examining Effects of D-cycloserine in Specific Phobia | Biotech Hunter | Biotech Hunter